M. Gunther et al., Rapid decline of antibodies after hepatitis A immunization in liver and renal transplant recipients, TRANSPLANT, 71(3), 2001, pp. 477-479
Background. Hepatitis A vaccine is safe and achieves good seroconversion ra
tes in liver (LTX) and renal (RTX) transplant recipients. Methods. A study
was performed to determine the anti-hepatitis A virus (HAV) antibody declin
e in LTX and RTX patients, and in healthy controls who have been immunized
with two doses of hepatitis A vaccine.
Results. LTX and RTX patients had a satisfactory seroconversion rate after
complete immunisation. However, 2 years later they had experienced a much m
ore rapid antibody decline than controls, and only 59% of LTX and 26% of RT
X seroconverters showed titres above the cut-off level defined as protectiv
e.
Conclusions. Patients on immunosuppressive therapy may not be adequately pr
otected against hepatitis A a few years after vaccination and alternative v
accination schemes may have to be considered.